Femasys, Inc. (FEMY)
2.94
-0.04
(-1.34%)
USD |
NASDAQ |
Aug 25, 12:18
Femasys Total Liabilities (Quarterly) : 8.259M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.259M |
| March 31, 2026 | 9.205M |
| December 31, 2025 | 14.85M |
| September 30, 2025 | 11.73M |
| June 30, 2025 | 12.27M |
| March 31, 2025 | 11.28M |
| December 31, 2024 | 10.14M |
| September 30, 2024 | 9.615M |
| June 30, 2024 | 9.026M |
| March 31, 2024 | 8.763M |
| December 31, 2023 | 9.403M |
| September 30, 2023 | 4.410M |
| Date | Value |
|---|---|
| June 30, 2023 | 1.438M |
| March 31, 2023 | 1.511M |
| December 31, 2022 | 1.653M |
| September 30, 2022 | 2.025M |
| June 30, 2022 | 2.183M |
| March 31, 2022 | 2.040M |
| December 31, 2021 | 22.62M |
| September 30, 2021 | 2.511M |
| June 30, 2021 | 3.108M |
| March 31, 2021 | 60.25M |
| December 31, 2020 | 59.42M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
| Alphatec Holdings, Inc. | 779.49M |
| AtriCure, Inc. | 160.21M |
| Baxter International, Inc. | 13.61B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.29M |
| Shareholders Equity (Quarterly) | 4.031M |
| Debt to Equity Ratio | 1.188 |
| Current Ratio | 2.144 |
| Net Debt Paydown Yield | 4.55% |